Facebook Twitter Youtube Vk Rss
Facebook Twitter Youtube Vk Rss
  Trending
Waterdrop hits 52-Week High on Day before it Reports Q3 2022 Financial Results December 5, 2022
Nkarta provides Updated Anti-CD19 Allogeneic CAR-NK Cell Therapy NKX019 Clinical Data for Patients with Relapsed or Refractory Non-Hodgkin Lymphoma December 5, 2022
Yumanity Therapeutics plans to Pay Special Dividend from Proposed Asset Sale to Janssen and Merger with Kineta December 5, 2022
Eos Energy Enterprises Buy Rating at Stifel Nicolaus December 2, 2022
Phase 2B/3 ANAVEX(R)2-73 (Blarcamesine) Study Meets Primary and Key Secondary Endpoints December 2, 2022
Next
Prev

24/7 Market News – (NASDAQ: MREO) shares are up again this morning $1.51 and more than 15% on more than 17,491 trades as traders await news on AstraZeneca buyout possibilities.

  • Jun 21, 2022 at 7:18 AM

Mereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout

https://www.zacks.com/stock/news/1941204/mereo-biopharma-mreo-up-as-astrazeneca-reportedly-eyes-buyout?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1941204

RelatedNews

Page 1 of 2
12

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Follow Us

Facebook-f Twitter Youtube

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.